1Drossman DA. The functional gastrointestinal disorders and the Rome III process[J]. Gastroenterology, 2006, 130 (5) ; 1377-1390. DOI: 10. 1053/j. gastro. 2006.03. 008.
4Du Y, Su T, Song X, et al. Efficacy and safety of cinitapride in the treatment of mild to moderate postprandial distress syndrome-predominant functional dyspepsia [J].J Clin Gastroenterol, 2014,48 (4) 328-335.
5Xiao G, Xie X, Fan J, et al. Efficacy and safety of acotiamide for the treatment of functional dyspepsia., systematic review and meta-analysis [J/OL] Scientific World Journal, 2014, 2014.. 541950 [2014-08-12 ]. http://www, hindawi, com/ journals/tswj/2014/541950/. DOI.. 10. 1155/2014/541950.
6Pasalar M, Choopani R, Mosaddegh M, et al. Efficacy and safety of jollab to treat functional dyspepsia: a randomized placebo-controlled clinical trial [J].Explore (NY), 2015, 11(3) :199-207. DOI: 10. 1016/j. explore. 2015.02. 007.
7Matsueda K, Hongo M, Tack J, et al. Clinical trial:dose- dependent therapeutic efficacy of aeotiamide hydrochloride (Z- 338) in patients with functional dyspepsia-100 mg t. i. d. is an optimal dosage [J]. Neurogastroenterol Motil, 2010,22 (6) : 618-e173. DOI:10. 1111/j. 1365-2982. 2009. 01449. x.
8Talley NJ, Locke GR, Saito YA,et al. Effect of amitriptyline and eseitalopram on functional dyspepsia: a multicenter, randomized controlled study[J].Gastroenterology, 2015, 149(2) :340-349. DOI:10. 1053/j. gastro. 2015.04. 020.
9Du HG, Ming L, Chen SJ,et al. Xiaoyao pill for treatment of functional dyspepsia in perimenopausal women with depression [J]. World J Gastroenterol, 2014, 20 (44) ; 16739-16744. DOI: 10. a748/wjg, v20. i44. 16739.
